META equity

long / 2-8 weeks

ready

Investment Memo

Thesis

META offers rare large-cap quality at a merely reasonable earnings multiple after a sharp drawdown left the stock below key moving averages. The business still delivers 81.94% gross margin, 41.21% operating margin, 19.96% ROIC, strong balance-sheet metrics, and $46.109B of free cash flow despite massive capex, creating an attractive setup for a near-term rerating if price action stabilizes.

Catalyst

Potential rerating as META reclaims the 50-day EMA at 596.44 and 50-day average at 605.23 after sentiment-driven weakness despite elite margins, cash generation, and valuation support versus peers.

Invalidation

Exit if META closes below 560, or if new company disclosures indicate free cash flow is tracking materially below $46.109B without a credible capex payoff, as that would break the quality-and-rerating thesis.

Rationale

This deserves a draft ticket because the report identifies a high-quality franchise with superior margins and returns trading at a non-elite multiple while sentiment and trend remain weak. The setup supports a defined-risk starter position sized to keep loss under 50 bps of NAV, with upside to a modest rerating and clear technical and fundamental invalidation criteria.

Risk Review

NAV Risk

49.7 bps

Gross Delta

11.1%

Net Delta

11.1%

Scenario Loss

$496.66

Inside PM-conservative 25-50 bps lane. No leverage or autonomous broker execution is permitted in v1.

Sector exposure requires PM review before manual execution.

Correlation/factor exposure requires PM review against current book.

Manual Order Ticket

{
  "mode": "personal_desk",
  "side": "BUY",
  "symbol": "META",
  "quantity": 19,
  "manualOnly": true,
  "instrumentType": "equity",
  "limitReference": 586.14,
  "orderTypeSuggestion": "LIMIT"
}